Identifiers
Database identifiers and provenance.
- Ligand ID
ATF- PDB
1dvr- UniProt (similar protein)
P07170- Target protein
- PA3686
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 541.2
- LogP ≤ 5 -0.93
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 13
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 269.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)(O)O[P@@](=O)(C(F)(F)P(=O)(O)O)O)O)O)Nc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)(O)O[P@@](=O)(C(F)(F)P(=O)(O)O)O)O)O)N
InChI=1S/C11H16F2N5O12P3/c12-11(13,31(21,22)23)32(24,25)30-33(26,27)28-1-4-6(19)7(20)10(29-4)18-3-17-5-8(14)15-2-16-9(5)18/h2-4,6-7,10,19-20H,1H2,(H,24,25)(H,26,27)(H2,14,15,16)(H2,21,22,23)/t4-,6-,7-,10-/m1/s1InChI=1S/C11H16F2N5O12P3/c12-11(13,31(21,22)23)32(24,25)30-33(26,27)28-1-4-6(19)7(20)10(29-4)18-3-17-5-8(14)15-2-16-9(5)18/h2-4,6-7,10,19-20H,1H2,(H,24,25)(H,26,27)(H2,14,15,16)(H2,21,22,23)/t4-,6-,7-,10-/m1/s1
ODWAWOIUPXBZKQ-KQYNXXCUSA-NODWAWOIUPXBZKQ-KQYNXXCUSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00406' 'PF05191
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand ATF →
- PDB RCSB structure 1dvr →
- UniProt UniProt P07170 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ATF”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3686.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).